Thomas B Smith is Chief Medical Officer of BIODELIVERY SCIENCES INTERNATIONAL INC. Currently has a direct ownership of 0 shares of BDSI, which is worth approximately $0. The most recent transaction as insider was on Mar 22, 2022, when has been sold 52,530 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Thomas B Smith Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 22 2022
SELL
Other acquisition or disposition
-
52,530 Reduced 100.0%
0 Common Stock
Jan 31 2022
BUY
Exercise of conversion of derivative security
-
15,215 Added 22.46%
52,530 Common Stock
Jan 27 2022
BUY
Exercise of conversion of derivative security
-
17,361 Added 31.75%
37,315 Common Stock
Feb 01 2021
BUY
Exercise of conversion of derivative security
-
7,667 Added 27.76%
19,954 Common Stock
Jan 29 2021
BUY
Exercise of conversion of derivative security
-
7,548 Added 38.05%
12,287 Common Stock

Also insider at

COLL
COLLEGIUM PHARMACEUTICAL, INC Healthcare
TBS

Thomas B Smith

Chief Medical Officer
Raleigh, NC

Track Institutional and Insider Activities on BDSI

Follow BIODELIVERY SCIENCES INTERNATIONAL INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BDSI shares.

Notify only if

Insider Trading

Get notified when an Biodelivery Sciences International Inc insider buys or sells BDSI shares.

Notify only if

News

Receive news related to BIODELIVERY SCIENCES INTERNATIONAL INC

Track Activities on BDSI